Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray

Journal of Medical Virology

Volumn 83, Issue 8, 2011, Pages 1358-1361

  Bryant, Dean ^a   Rai, Nirmala ^a   Rowlands, Gareth ^a   Hibbitts, Sam ^a   Jones, Joanne ^a   Tristram, Amanda ^a   Fiander, Alison ^a   Powell, Ned ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Human papillomavirus; Papillocheck; Vulval intraepithelial neoplasia

Indexed keywords

PAPILLOCHECK; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PATIENT ASSESSMENT; PROPHYLAXIS; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; FEMALE; GENOTYPE; GREAT BRITAIN; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; VULVAR NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 79959206951     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22107     Document Type: Article

References (26)

1. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN. 2001. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 61: 192-196.
2. Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC. 2003. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res 9: 5205-5213.
3. Bonvicini F, Venturoli S, Ambretti S, Paterini P, Santini D, Ceccarelli C, Zerbini M, Musiani M. 2005. Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. J Med Virol 77: 102-106.
4. Daayana S, Elkord E, Winters U, Pawlita M, Roden R, Stern PL, Kitchener HC. 2010. Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer 102: 1129-1136.
5. Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C. 2009. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. J Virol Methods 156: 77-83.
6. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. 2009. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 124: 1626-1636.
7. Fiander AN, Tristram AJ, Davidson EJ, Tomlinson AE, Man S, Baldwin PJ, Sterling JC, Kitchener HC. 2006. Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: Clinical results from a multicenter phase II trial. Int J Gynecol Cancer 16: 1075-1081.
8. Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T. 2002. Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 21: 1876-1881.
9. Halfon P, Benmoura D, Khiri H, Penaranda G, Blanc B, Riggio D, Sandri MT. 2009. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck((R)) HPV-screening assay. J Clin Virol 47: 38-42.
10. Hart WR. 2001. Vulvar intraepithelial neoplasia: Historical aspects and current status. Int J Gynecol Pathol 20: 16-30.
11. Hesselink AT, Heideman DA, Berkhof J, Topal F, Pol RP, Meijer CJ, Snijders PJ. 2010. Comparison of the clinical performance of the PapilloCheck HPV detection with GP5+/6+-PCR-EIA in population-based cervical screening. J Clin Microbiol 48: 797-801.
12. Hibbitts S, Jones J, Powell N, Dallimore N, McRea J, Beer H, Tristram A, Fielder H, Fiander AN. 2008. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: A cross-sectional study. Br J Cancer 99: 1929-1933.
13. Jones J, Powell NG, Tristram A, Fiander AN, Hibbitts S. 2009. Comparison of the PapilloCheck DNA microarray human papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set. J Clin Virol 45: 100-104.
14. Joura EA. 2002. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia. Curr Opin Obstet Gynecol 14: 39-43.
15. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GWK, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J. 2007. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11 16, and 18) L1 virus- like-particle vaccine against high-grade vulval and vaginal lesions: A combined analysis of three randomised clinical trials. The Lancet 369: 1693-1702.
16. MacLean AB. 2004. Vulval cancer: The past 100 years, and into the next century: The Presidential Oration, British Society for the Study of Vulval Disease, 2002. J Obstet Gynaecol 24: 491-497.
17. MacLean AB. 2006. Vulval cancer: Prevention and screening. Best Pract Res Clin Obstet Gynaecol 20: 379-395.
18. McCluggage WG. 2009. Recent developments in vulvovaginal pathology. Histopathology 54: 156-173.
19. Peto J, Gilham C, Fletcher O, Matthews FE. 2004. The cervical cancer epidemic that screening has prevented in the UK. Lancet 364: 249-256.
20. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, Haefner H, Neill S. 2005. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 50: 807-810.
21. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. 2009. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 113: 917-924.
22. Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O. 1990. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis 17: 15-19.
23. Todd RW, Etherington IJ, Luesley DM. 2002. The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia. Gynecol Oncol 85: 67-70.
24. Tristram A, Fiander A. 2005. Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia. Gynecol Oncol 99: 652-655.
25. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. 2008. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 68: 131-156.
26. Woo YL, Damay I, Stanley M, Crawford R, Sterling J. 2007. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. J Virol Methods 142: 226-230.